|
|
Volumn 14, Issue 7, 2014, Pages 1475-1476
|
|
Desensitization outcomes: Quantifying and questioning
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
PANEL REACTIVE ANTIBODY;
HLA ANTIGEN;
ANTIBODY MEDIATED REJECTION;
COMORBIDITY;
COMPLEMENT DEPENDENT CYTOTOXICITY;
DESENSITIZATION;
DIALYSIS;
EDITORIAL;
GLOMERULOPATHY;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEMODIALYSIS PATIENT;
HIGH RISK POPULATION;
HLA SYSTEM;
HUMAN;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MEDICAID;
MEDICARE;
OUTCOME ASSESSMENT;
PATIENT PREFERENCE;
PRIORITY JOURNAL;
RACE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REGISTER;
RENAL REPLACEMENT THERAPY;
RISK FACTOR;
ADULT;
ALLOGRAFT;
COHORT ANALYSIS;
CONTROLLED STUDY;
FEMALE;
KIDNEY GRAFT;
MALE;
STANDARDIZATION;
BLOOD GROUP INCOMPATIBILITY;
GRAFT REJECTION;
IMMUNOLOGY;
LEGISLATION AND JURISPRUDENCE;
STATISTICS AND NUMERICAL DATA;
SUPPLY AND DISTRIBUTION;
ANTIBODIES;
BLOOD GROUP INCOMPATIBILITY;
FEMALE;
GRAFT REJECTION;
HLA ANTIGENS;
HUMANS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
|
|
EID: 84903150840
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/ajt.12789 Document Type: Editorial |
|
Times cited : (2)
|
|
References (5)
|
